Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes
N/A
N/A
20 Years
N/A
20 Years
Not Enrolling
Both
Paediatric Osteosarcomas
Both
Paediatric Osteosarcomas
Trial Information
Study of Prognostic Value by Molecular Analysis in Paediatric Osteosarcomas of the Chromosomal Regions Containing Rb, p16, p53, Cycline D1, APC, erbB2 and C-met Genes
Inclusion Criteria:
- Patients under 20 years of age with primary osteosarcomas
- Under treatment by the French Society of Paediatric Oncology OS 94 protocol
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Presence of molecular abnormalities statistically linked to survival or response to chemotherapy
Principal Investigator
Annie BOILLETOT-BABIN, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Service de Pédiatrie 3, Hôpital de Hautepierre
Authority:
France: Ministry of Health
Study ID:
2472
NCT ID:
NCT00223184
Start Date:
March 2003
Completion Date:
August 2011
Related Keywords:
- Paediatric Osteosarcomas
- Osteosarcoma
Name | Location |
|---|
